Pages that link to "Q35754595"

The following pages link to Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging (Q35754595):

Displaying 46 items.

• Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior (Q24645994) (← links)
• Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases (Q24650014) (← links)
• Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds (Q26749061) (← links)
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide (Q28131750) (← links)
• Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease (Q29617986) (← links)
• Cognitive effects of cell-derived and synthetically derived Aβ oligomers (Q30495253) (← links)
• Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. (Q31840691) (← links)
• Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders (Q33716773) (← links)
• The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. (Q33808415) (← links)
• Oligomerizaiton and fibril asssembly of the amyloid-beta protein. (Q33971276) (← links)
• Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein (Q33998693) (← links)
• Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process (Q34332006) (← links)
• Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains (Q34624644) (← links)
• Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins (Q34750660) (← links)
• Amyloid-β as a Modulator of Synaptic Plasticity (Q34814145) (← links)
• Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-β peptide via single-oligomer spectroscopy (Q35534356) (← links)
• Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation (Q35787262) (← links)
• Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain (Q35829722) (← links)
• Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy (Q35928266) (← links)
• The keystone of Alzheimer pathogenesis might be sought in Aβ physiology (Q36113757) (← links)
• The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species. (Q36119212) (← links)
• Hereditary cerebral hemorrhage with amyloidosis-Dutch type (Q36355476) (← links)
• Alzheimer's disease: synaptic dysfunction and Abeta (Q37636545) (← links)
• Low-n oligomers as therapeutic targets of Alzheimer's disease (Q37829762) (← links)
• Computational Insights into the Development of Novel Therapeutic Strategies for Alzheimer’s Disease (Q37855869) (← links)
• Alzheimer's disease: synapses gone cold (Q37922808) (← links)
• Potent amyloidogenicity and pathogenicity of Aβ43. (Q39513749) (← links)
• Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity (Q39702813) (← links)
• Molecular dynamics simulation of amyloid beta dimer formation (Q40298901) (← links)
• Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein (Q40950151) (← links)
• Alzheimer beta-amyloid homodimers facilitate A beta fibrillization and the generation of conformational antibodies (Q42163313) (← links)
• Brain amyloid β protein and memory disruption in Alzheimer’s disease (Q42255091) (← links)
• Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. (Q43662767) (← links)
• Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein (Q43685887) (← links)
• Assemblies of Alzheimer's peptides A beta 25-35 and A beta 31-35: reverse-turn conformation and side-chain interactions revealed by X-ray diffraction. (Q44341975) (← links)
• Membrane-bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons (Q46633414) (← links)
• Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. (Q47763676) (← links)
• The search for an amyloid solution (Q48454174) (← links)
• Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta (Q48463395) (← links)
• Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. (Q48569616) (← links)
• Single App knock-in mouse models of Alzheimer's disease. (Q50670713) (← links)
• Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease. (Q52637940) (← links)
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. (Q53265841) (← links)
• Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly (Q53317391) (← links)
• Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain (Q88450906) (← links)
• Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain (Q91590650) (← links)